Sorry, you need to enable JavaScript to visit this website.

GREENSTONE LLC INTRODUCES
TOLTERODINE TARTRATE EXTENDED RELEASE CAPSULES
Authorized Generic of DETROL® LA (tolterodine tartrate extended release capsules)

PEAPACK, NJ, January 2016—Greenstone LLC, a US-based subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of tolterodine tartrate extended release capsules to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strengths of 2 mg x 30 capsules per bottle, 2 mg x 90 capsules per bottle, 4 mg x 30 capsules per bottle, and 4 mg x 90 capsules per bottle.

Greenstone’s tolterodine tartrate extended release capsules product is the authorized generic of, and equivalent to the innovator’s product, DETROL® LA (tolterodine tartrate extended release capsules). This new authorized generic adds to Greenstone’s consistently growing line of products and is backed by the distribution and customer service support of Pfizer Inc., one of the world’s premiere biopharmaceutical companies. As a subsidiary of Pfizer, Greenstone operates under the same values and commitment to bring quality pharmaceutical products to customers, payers, and the patients it serves.

See the Full Prescribing Information for Greenstone’s tolterodine tartrate extended release capsules at http://www.greenstonellc.com/product-list.aspx.

For more information about Greenstone LLC and its products, visit http://greenstonellc.com.